Zai Lab Limited American Depositary Shares
Symbol: ZLAB (NASDAQ)
28.00
▼ (-3.76%) -1.095
Company Description:
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Key Stats
- Today's Open: $28.1
- Today's High: $28.999
- Today's Low: $27.764
- Today's Volume: 690.29K
- Yesterday Close: $29.09
- Yesterday High: $29.49
- Yesterday Low: $28.8101
- Yesterday Volume: 463.12K
- Last Min Volume: 25
- Last Min High: $27.995
- Last Min Low: $27.995
- Last Min VWAP: $27.995
Company Profile
- Name: Zai Lab Limited American Depositary Shares
- Website: https://www.zailaboratory.com
- Listed Date: 2017-09-20
- Location: SHANGHAI,
- Market Status: Active
- CIK Number: 0001704292
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $3.24B
- Round Lot: 100
- Outstanding Shares: 111.27M
- Asset Type: ADRC
RECENT FILINGS FOR ZLAB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-16 | 8-K | View |
| 2025-10-03 | 4 | View |
| 2025-10-02 | 144 | View |
| 2025-09-12 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-18 | 4 | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-15 | 144 | View |
| 2025-08-15 | 144 | View |
| 2025-08-14 | 4 | View |
| 2025-08-14 | SCHEDULE 13G | View |
| 2025-08-13 | 144 | View |
| 2025-08-12 | 4 | View |
| 2025-08-12 | 4 | View |
| 2025-08-12 | 4 | View |
| 2025-08-12 | 144 | View |
| 2025-08-12 | SCHEDULE 13G/A | View |